Oncology Diagnostics: Global Markets
Report Scope
This report analyzes the oncology diagnostics market and the competitive landscape. The profiles of several leading companies, including their revenues, product portfolios and recent activities are also examined. The report analyzes market dynamics, including drivers, limitations, challenges and opportunities, and discusses current and potential market size. The report will enable companies in the industry to make informed decisions about the production and licensing of goods and services.
The market is divided into the following segments: diagnostic imaging, tumor biomarker tests, endoscopy, biopsy, hematoxylin and eosin (H&E) staining, immunohistochemistry (IHC), in situ hybridization (ISH), polymerase chain reaction (PCR), next generation sequencing (NGS) and others (cytology, microarrays, exosomes, flow cytometry, sanger sequencing, pyrosequencing etc.). The market is segmented by application into breast cancer, lung cancer, colorectal cancer, prostate cancer, gastric cancer and other cancers (lip, oral/cavity, liver/gallbladder, pancreas, melanoma, kidney, bladder, brain, central nervous system, thyroid, Hodgkin lymphoma, non-Hodgkin lymphoma, multiple myeloma and leukemia). By end user, the market is segmented into hospitals/cancer centers/clinics, diagnostic imaging centers/reference laboratories, and other end users (physician offices, research, academic institutes, national cancer registries and contract research organizations).
Regional market analysis is provided for North America, Europe, Asia-Pacific, South America and Middle East and Africa. The report also provides country-level analyses of markets and market segments. North America comprises the U.S., Canada and Mexico, while South America includes Brazil, Argentina and the rest of South America. In Europe, major countries covered are Germany, France, the U.K., Italy and Spain, along with the rest of Europe, which includes Switzerland, Denmark, Norway, Poland, Belgium, Austria, the Netherlands, Sweden, Russia and others. The Asia-Pacific region consists of Japan, China and India, as well as the rest of Asia-Pacific (Australia, New Zealand, Taiwan, Singapore, Malaysia, Thailand, the Philippines, South Korea, Indonesia etc.), and the Middle East and Africa.
The base year for the study is 2023, 2024 is the estimated year, with projections through 2029, including compound annual growth rates (CAGRs) for the forecast period.
Report Includes
This report analyzes the oncology diagnostics market and the competitive landscape. The profiles of several leading companies, including their revenues, product portfolios and recent activities are also examined. The report analyzes market dynamics, including drivers, limitations, challenges and opportunities, and discusses current and potential market size. The report will enable companies in the industry to make informed decisions about the production and licensing of goods and services.
The market is divided into the following segments: diagnostic imaging, tumor biomarker tests, endoscopy, biopsy, hematoxylin and eosin (H&E) staining, immunohistochemistry (IHC), in situ hybridization (ISH), polymerase chain reaction (PCR), next generation sequencing (NGS) and others (cytology, microarrays, exosomes, flow cytometry, sanger sequencing, pyrosequencing etc.). The market is segmented by application into breast cancer, lung cancer, colorectal cancer, prostate cancer, gastric cancer and other cancers (lip, oral/cavity, liver/gallbladder, pancreas, melanoma, kidney, bladder, brain, central nervous system, thyroid, Hodgkin lymphoma, non-Hodgkin lymphoma, multiple myeloma and leukemia). By end user, the market is segmented into hospitals/cancer centers/clinics, diagnostic imaging centers/reference laboratories, and other end users (physician offices, research, academic institutes, national cancer registries and contract research organizations).
Regional market analysis is provided for North America, Europe, Asia-Pacific, South America and Middle East and Africa. The report also provides country-level analyses of markets and market segments. North America comprises the U.S., Canada and Mexico, while South America includes Brazil, Argentina and the rest of South America. In Europe, major countries covered are Germany, France, the U.K., Italy and Spain, along with the rest of Europe, which includes Switzerland, Denmark, Norway, Poland, Belgium, Austria, the Netherlands, Sweden, Russia and others. The Asia-Pacific region consists of Japan, China and India, as well as the rest of Asia-Pacific (Australia, New Zealand, Taiwan, Singapore, Malaysia, Thailand, the Philippines, South Korea, Indonesia etc.), and the Middle East and Africa.
The base year for the study is 2023, 2024 is the estimated year, with projections through 2029, including compound annual growth rates (CAGRs) for the forecast period.
Report Includes
- 94 data tables and 59 additional tables
- Analyses of global market trends for oncology diagnostics, with market revenue data from 2021 to 2024, forecasts and projected CAGRs through 2029
- Estimates of the size and growth of the global market, and a corresponding market share analysis by product type, application, end user, and region
- Facts and figures pertaining to the major market dynamics, opportunities and challenges, emerging technologies, regulations, and impacts of macroeconomic variables
- Insights derived from the Porter’s Five Forces model, as well as global supply chain and PESTLE analyses
- Coverage of treatments in development for late%li%and early-stage oncolytic viruses, along with epidemiological information, data corresponding to cancer incidence and mortality trends
- Evaluation of recent patent activity featuring key granted and published patents
- Insights into oncology therapeutics research activity, emerging technologies, clinical trials and pipeline products
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
- Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
- Company profiles of major players within the industry, including F. Hoffmann-La Roche Ltd., Danaher Corp., Agilent Technologies Inc., Siemens Healthineers AG, and GE HealthCare
CHAPTER 1 EXECUTIVE SUMMARY
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Strategic Initiatives
Conclusion
CHAPTER 2 MARKET OVERVIEW
Overview
Macroeconomic Factors Analysis
Impact of the U.S.-China Trade War
Porter’s Five Forces Analysis in the Oncology Market
Potential of New Entrants (Moderate to Low)
Bargaining Power of Suppliers (Moderate to High)
Bargaining Power of Buyers (Moderate to High)
Threat of Substitute Products or Services (Low)
Industry Rivalry (High)
CHAPTER 3 MARKET DYNAMICS
Key Takeaways
Market Drivers
Rising Incidence of Cancer Cases
Demand for Earlier Intervention and Preventive Diagnostic Screening
Growing Adoption of Companion Diagnostics
Increasing Aging Population Worldwide
Market Opportunities
Expanding Cancer Screening
Enhancing Access to Advanced Technologies
Market Restraints
Complex Reimbursement Policies
Lack of Cancer Awareness
Cost of Oncology Diagnostic Tests
Turnaround Time of Oncology Diagnostics
Market Challenges
Lack of Skilled Professionals
Complex Sample Preparation and Handling
CHAPTER 4 REGULATORY LANDSCAPE
Market Regulations, by Top Country/Region
The U.S.
Europe
Japan
China
CHAPTER 5 EMERGING TECHNOLOGIES AND DEVELOPMENTS
Emerging Technologies
AI in Oncology Diagnostics
Multi-Cancer Early Detection (MCED)
Theranostics
Digital Pathology and AI Integration
Patent Analysis
Key Takeaways
CHAPTER 6 ONCOLOGY DIAGNOSTICS MARKET
Segment Breakdown
Global Market Insights
Market Breakdown by Product Type
Diagnostics Imaging
Endoscopy Devices
Tumor Biomarker Tests
Biopsy Devices
Hematoxylin and Eosin
Immunohistochemistry
In situ Hybridization
Polymerase Chain Reaction
Next-Generation Sequencing
Others
Market Breakdown by Application
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Gastric Cancer
Other Applications
Market Breakdown by End User
Hospitals, Cancer Centers and Clinics
Diagnostic Imaging and Reference Laboratories
Others
Geographic Breakdown
Market Breakdown, by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa (MEA)
CHAPTER 7 COMPETITIVE INTELLIGENCE
Company Share Analysis
Strategic Initiatives
CHAPTER 8 SUSTAINABILITY IN THE MARKET FOR ONCOLOGY DIAGNOSTICS: AN ESG PERSPECTIVE
Introduction to ESG
ESG Performance Analysis
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks from BCC
CHAPTER 9 APPENDIX
Research Methodology
References
Abbreviations
Company Profiles
ABBOTT
AGILENT TECHNOLOGIES INC.
BD
BIOMERIEUX
BIO-RAD LABORATORIES INC.
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
GE HEALTHCARE
ILLUMINA INC.
KONINKLIJKE PHILIPS N.V.
MERCK KGAA
MYRIAD GENETICS INC.
QIAGEN
SIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC INC.
ZYTOVISION GMBH
Other Emerging Players in the Oncology Diagnostics Market
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Strategic Initiatives
Conclusion
CHAPTER 2 MARKET OVERVIEW
Overview
Macroeconomic Factors Analysis
Impact of the U.S.-China Trade War
Porter’s Five Forces Analysis in the Oncology Market
Potential of New Entrants (Moderate to Low)
Bargaining Power of Suppliers (Moderate to High)
Bargaining Power of Buyers (Moderate to High)
Threat of Substitute Products or Services (Low)
Industry Rivalry (High)
CHAPTER 3 MARKET DYNAMICS
Key Takeaways
Market Drivers
Rising Incidence of Cancer Cases
Demand for Earlier Intervention and Preventive Diagnostic Screening
Growing Adoption of Companion Diagnostics
Increasing Aging Population Worldwide
Market Opportunities
Expanding Cancer Screening
Enhancing Access to Advanced Technologies
Market Restraints
Complex Reimbursement Policies
Lack of Cancer Awareness
Cost of Oncology Diagnostic Tests
Turnaround Time of Oncology Diagnostics
Market Challenges
Lack of Skilled Professionals
Complex Sample Preparation and Handling
CHAPTER 4 REGULATORY LANDSCAPE
Market Regulations, by Top Country/Region
The U.S.
Europe
Japan
China
CHAPTER 5 EMERGING TECHNOLOGIES AND DEVELOPMENTS
Emerging Technologies
AI in Oncology Diagnostics
Multi-Cancer Early Detection (MCED)
Theranostics
Digital Pathology and AI Integration
Patent Analysis
Key Takeaways
CHAPTER 6 ONCOLOGY DIAGNOSTICS MARKET
Segment Breakdown
Global Market Insights
Market Breakdown by Product Type
Diagnostics Imaging
Endoscopy Devices
Tumor Biomarker Tests
Biopsy Devices
Hematoxylin and Eosin
Immunohistochemistry
In situ Hybridization
Polymerase Chain Reaction
Next-Generation Sequencing
Others
Market Breakdown by Application
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Gastric Cancer
Other Applications
Market Breakdown by End User
Hospitals, Cancer Centers and Clinics
Diagnostic Imaging and Reference Laboratories
Others
Geographic Breakdown
Market Breakdown, by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa (MEA)
CHAPTER 7 COMPETITIVE INTELLIGENCE
Company Share Analysis
Strategic Initiatives
CHAPTER 8 SUSTAINABILITY IN THE MARKET FOR ONCOLOGY DIAGNOSTICS: AN ESG PERSPECTIVE
Introduction to ESG
ESG Performance Analysis
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks from BCC
CHAPTER 9 APPENDIX
Research Methodology
References
Abbreviations
Company Profiles
ABBOTT
AGILENT TECHNOLOGIES INC.
BD
BIOMERIEUX
BIO-RAD LABORATORIES INC.
DANAHER CORP.
F. HOFFMANN-LA ROCHE LTD.
GE HEALTHCARE
ILLUMINA INC.
KONINKLIJKE PHILIPS N.V.
MERCK KGAA
MYRIAD GENETICS INC.
QIAGEN
SIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC INC.
ZYTOVISION GMBH
Other Emerging Players in the Oncology Diagnostics Market
